Pulmonx Corp
NASDAQ:LUNG
Pulmonx Corp
Gross Profit
Pulmonx Corp
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Pulmonx Corp
NASDAQ:LUNG
|
Gross Profit
$50.8m
|
CAGR 3-Years
34%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Cooper Companies Inc
NYSE:COO
|
Gross Profit
$2.4B
|
CAGR 3-Years
16%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Gross Profit
$2.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
0%
|
CAGR 10-Years
3%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Gross Profit
$2.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
18%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Gross Profit
$874.3m
|
CAGR 3-Years
82%
|
CAGR 5-Years
38%
|
CAGR 10-Years
26%
|
See Also
What is Pulmonx Corp's Gross Profit?
Gross Profit
50.8m
USD
Based on the financial report for Dec 31, 2023, Pulmonx Corp's Gross Profit amounts to 50.8m USD.
What is Pulmonx Corp's Gross Profit growth rate?
Gross Profit CAGR 5Y
33%
Over the last year, the Gross Profit growth was 27%. The average annual Gross Profit growth rates for Pulmonx Corp have been 34% over the past three years , 33% over the past five years .